Eaton Vance Corp. Report for the Three Months and Fiscal Year Ended October 31, 2020
© 2020 PR Newswire. All Rights Reserved.
FDA Approves Aurinia Pharmaceuticals' (Nasdaq: AUPH / TSX: AUP) LUPKYNIS (voclosporin) for Adult Patients with Active Lupus Nephritis




